Novel Drug Therapeutics in Celiac Disease: A Pipeline Review Sanskriti VarmaSuneeta Krishnareddy Leading Article 17 October 2022 Pages: 1515 - 1526
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection Sahil KhannaMaha AssiPaul Feuerstadt Original Research Article Open access 26 October 2022 Pages: 1527 - 1538
Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection Sahil KhannaMaha AssiPaul Feuerstadt Correction Open access 07 November 2022 Pages: 1539 - 1539
Ripretinib: A Review in Gastrointestinal Stromal Tumours as Fourth-or Later-Line of Therapy Simon FungMatt Shirley Adis Drug Evaluation 25 October 2022 Pages: 1541 - 1548
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids Yahiya Y. Syed Adis Drug Evaluation Open access 04 November 2022 Pages: 1549 - 1556